Paola Grandi, PhD Birth Date - American Society of Gene & Cell ...

11. Bozac, Berto E., VasquezF., Grandi P., Caputo A., Mnaservigi R., Ensoli B., Marconi P. Expression of HumanImmunodeficiency Virus Type 1 tat from a replication-deficient herpes simplex vector induces antigen-specific Tcell responses. Vaccine. 2006 Nov 30;24(49-50):7148-58. Epub 2006 Jul 12.12. Grandi P., Fernadez J., Szemntirmai O., Carter R., Breakefield X., Sena- Esteves M. Targeting HSV-1 virions forspecific binding to Epidermal Growth Factor Receptro-vIII on Tumor cells. (2006) Mol. Therapy. 13: 16813. Trevor McKee 1 , Paola Grandi 1 , Wilson Mok, George Alexandrakis, Numpon Insin, John P. Zimmer, Moungi G.Bawendi, Yves Boucher Xandra O. Breakefield and Rakesh K. Jain. Degradation of fibrillar collagen within solidtumors improves the efficacy of oncolytic viral therapy (2006). Cancer Research 66 (5): 2509-13 1 authorscontributed equally14. Grandi P., Wang S., Schuback D., Krasnykh V., Spear M., Curiel D., Manservigi R., Breakefield X. HSV-1virions engineered for specific binding to cell surface receptor (2004) Mol. Therapy, 9: 419-27.15. Grandi P., Spear M., Breakefield X., Wang S. Targeting HSV-1 vectors (2004). Methods, 33:179-186.16. Spear M., Schuback D., Miyata K., Grandi P., Sun F., Yoo L., Nguyen A., Brandt C.R., Breakefield X. HSV-1amplicon peptide display vector (2003). Journal of Virological Methods; 107: 71-79.17. Garrafa E., Argnani R, Marconi P., Grandi P., Zerbinati A., Bozac A., Berto E., Gardo G., Fugagnoli S.,Catalano C., Grossi M.P., Balboni P.G., Manservigi R. Virus erpetici come vettori vaccinali. (2003). L’IgieneModerna 119: 251-266.18. Grandi P., Wang S., Schuback D., Krasnykh V., Spear M., Curiel D., Manservigi R., Breakefield X. HSV-1amplicon vector engineered for specific binding to pseudo His-tag receptor. (2002) Mol. Ther. 5: 320.19. Caselli E., Grandi P., Argnani R., Balboni P.G., Braga F. and Manservigi R. Mice genetic immunization withplasmid DNA encoding a secreted form of HSV-1 gB1 induce a protective immune response against HSV-1infection and establishment of latency (2001). Intervirology; 44: 1-7.20. Monini, P., de Lellis L, Rimesi, P., GRANDI P., Franco M, Leone L, Rosso R, Rossi T., Aiuti F, Ledi G. L.,Ensoli, B., Cassai, E (1997). Presence of HHV-8 DNA in semen of inmmunocompetent HIV-negative individualsfrom different geographical areas in Italy. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESAND HUMAN RETROVIROLOGY, ISSN: 1077-9450Book Chapters:1. Grandi, P., Bein, K., Hadjipanayis, C. G., Wolfe, D., Breakefield, X. O. Glorioso, J.C. “Application of HSV-1Vectors to the Treatment of Cancer”. "Viral Therapy of Cancer"Book, edited by Kevin Harrington, HardevPandha and Richard Vile (April 2008).2. Kohn, D.B., Carter, B., Glorioso, J.C. , Grandi P. “Gene Therapy and Viruses”. Clinical Virology. Chapter 20.2008PROFESSIONAL ACTIVITIES2005-2010 Assistant Editor for the Nature Group Journal, Gene Therapy2010-present ASGCT webtaskforce2011 ASGCT Cancer Gene & Cell Therapy Commette2012 Founder of ACAREF: Allied Community Ataxia Research FoundationTEACHING EXPERIENCE2008-present Integrated Cases Studies (ICS) course – Medical Students2010– present Experimental Virology - MVM PhD program2010 Medical Microbiology (MS1)ACTIVERESEARCH3